Transplantation of normal and DMD myoblasts expressing the telomerase gene in SCID mice

Biochemical and Biophysical Research Communications

Volumn 272, Issue 2, 2000, Pages 362-369

  Seigneurin Venin, Sophie ^a   Bernard, Valérie ^a   Moisset, Pierre Alain ^a   Ouellette, Michel M ^b   Mouly, Vincent ^c   Di Donna, Silvia ^c   Wright, Woodring E ^b   Tremblay, Jacques P ^a  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c CNRS   (France)

Author keywords

Duchenne muscular dystrophy; Myoblast transplantation; SCID mouse; Telomerase gene expression

Indexed keywords

TELOMERASE; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSPLANTATION; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; ENZYME ACTIVITY; ENZYME SUBUNIT; GENE EXPRESSION; LIFESPAN; MOUSE; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; TELOMERE;

ANIMALIA;

EID: 0034616678     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.2735     Document Type: Article

References (36)

1. Gussoni E., Pavlath G. K., Lanctot A. M., Sharma K. R., Miller R. G., Steinman L., Blau H. M. Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation. Nature. 356:1992;435-438.
2. Karpati G., Ajdukovic D., Arnold D., Gledhill R. B., Guttman R., Holland P., Koch P. A., Shoubridge E., Spence D., Vanasse M., Watters G. V., Abrahamowicz M., Duff C., Worton R. G. Myoblast transfer in Duchenne muscular dystrophy. Ann. Neurol. 34:1993;8-17.
3. Mendell J. R., Kissel J. T., Amato A. A., King W., Signore L., Prior T. W., Sahenk Z., Benson S., McAndrew P. E., Rice R., Nagaraja H., Stephens R., Lantry L., Morris G. E., Burghes A. H. M. Myoblast transfer in the treatment of Duchenne's muscular dystrophy. N. Engl. J. Med. 333:1995;832-838.
4. Law P. K., Goodwin T. G., Fang Q., Deering M. B., Duggirala V., Larkin C., Florendo J. A., Li H. J., Chen M., Cormett J., Li L. M., Shirzad A., Quinley T., Yoo T. J., Holcomb R. Cell transplantation as an experimental treatment for Duchenne muscular dystrophy. Cell Transplant. 2:1993;485-505.
5. Tremblay J. P., Bouchard J. P., Malouin F., Théau D., Cottrell F., Collin H., Rouche A., Gilgenkrantz S., Abbadi N., Tremblay M., Tomé F. M. S., Fardeau M. Myoblast transplantation between monozygotic twin girl carriers of Duchenne muscular dystrophy. Neuromusc. Disord. 3:1993;583-592.
6. Tremblay J. P., Guérette B. Myoblast transplantation: A brief review of the problems and of some solutions. Basic Appl. Myol. 7:1997.
7. Kinoshita I., Vilquin J. T., Guérette B., Asselin I., Roy R., Tremblay J. P. Very efficient myoblast allotransplantation in mice under FK506 immunosuppression. Muscle Nerve. 17:1994;1407-1415.
8. Kinoshita I., Vilquin J. T., Tremblay J. P. Mechanism of increasing dystrophin-positive myofibers by myoblast transplantation: Study using mdx/β-Galactosidase transgenic mice. Acta Neuropathol. 91:1996;489-493.
9. McDiarmid S. V., Busuttil R. W., Ascher N. L., Burdick J., D'Alessandro A. M., Esquivel C., Kalayoglu M., Klein A. S., Marsh J. W., Miller C. M., Schwartz M. E., Shaw B. W., So S. K. FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Transplantation. 59:1995;530-536.
10. Moisset P.-A., Skuk D., Asselin I., Goulet M., Roy B., Karpati G., Tremblay J. P. Successful transplantation of genetically corrected DMD myoblasts following ex vivo transduction with the dystrophin minigene. Biochem. Biophys. Res. Commun. 247:1998;94-99.
11. Webster C., Blau H. M. Accelerated age-related decline in replicative life-span of Duchenne muscular dystrophy myoblasts: Implications for cell and gene therapy. Somat. Cell Mol. Genet. 16:1990;557-565.
12. Simon L. V., Beauchamp J. R., O'Hare M., Olsen I. Establishment of long-term myogenic cultures from patients with Duchenne Muscular Dystrophy by retroviral transduction of a temperature-sensitive SV40 large T antigen. Exp. Cell Res. 224:1996;264-271.
13. Mouly V., Edom F., Decary S., Vicart P., Barbet J. P., Butler-Browne G. S. SV40 large T antigen interferes with adult myosin heavy chain expression, but not with differentiation of human satellite cells. Exp. Cell Res. 225:1996;268-276.
14. Morgan J. E., Beauchamp J. R., Pagel C. N., Peckham M., Ataliotis P., Jat P. S., Noble M. D., Farmer K., Partridge T. A. Myogenic cell lines derived from transgenic mice carrying a thermolabile T antigen: A model system for the derivation of tissue-specific and mutation-specific cell lines. Dev. Biol. 162:1994;486-498.
15. Moisset, P. A, Skuk, D, Vilquin, J. T, Ito, H, Asselin, I, Roy, B, Goulet, M, and, Tremblay, J. P. Transplantation of large T antigen-immortalized myoblasts, Gene Ther. (submitted).
16. Berghella L., De Angelis L., Coletta M., Berarducci B., Sonnino C., Salvatori G., Anthonissen C., Cooper R., Butler-Browne G. S., Mouly V., Ferrari G., Mavilio F., Cossu G. Reversible immortalization of human myogenic cells by site-specific excision of a retrovirally transferred oncogene [see comments]. Hum. Gene Ther. 10:1999;1607-1617.
17. Counter C. M., Avilion A. A., LeFeuvre C. E., Stewart N. G., Greider C. W., Harley C. B., Bacchetti S. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 11:1992;1921-1929.
18. Decary S., Mouly V., Hamida C. B., Sautet A., Barbet J. P., Butler-Browne G. S. Replicative potential and telomere length in human skeletal muscle: Implications for satellite cell-mediated gene therapy. Hum. Gene Ther. 8:1997;1429-1438.
19. Greider C. W., Blackburn E. H. Telomeres, telomerase, and cancer. Sci. Am. 274:1996;92-97.
20. Meyerson M., Counter C. M., Eaton E. N., Ellisen L. W., Steiner P., Caddle S. D., Ziaugra L., Beijersbergen R. L., Davidoff M. J., Liu Q., Bacchetti S., Haber D. A., Weinberg R. A. hEST2, the putative human telomerase catalytic subunit gene, is up- regulated in tumor cells and during immortalization. Cell. 90:1997;785-795.
21. Nakamura T. M., Morin G. B., Chapman K. B., Weinrich S. L., Andrews W. H., Lingner J., Harley C. B., Cech T. R. Telomerase catalytic subunit homologs from fission yeast and human. Science. 277:1997;955-959.
22. Bodnar A. G., Ouellette M., Frolkis M., Holt S. E., Chiu C.-P., Morin G. B., Harley C. B., Shay J. W., Lichtsteiner S., Wright W. E. Extension of life-span by introduction of telomerase into normal human cells. Science. 279:1998;349-352.
23. Morgenstern J. P., Land H. Advanced mammalian gene transfer: High titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18:1990;3587-3596.
24. Kim N. W., Piatyszek M. A., Prowse K. R., Harley C. B., West M. D., Ho P. L., Coviello G. M., Wright W. E., Weinrich S. L., Shay J. W. Specific association of human telomerase activity with immortal cells and cancer. Science. 266:1994;2011-2015.
25. Weller B., Karpati G., Lehnert S., Carpenter S., Ajdukovic B., Holland P. Inhibition of myosatellite cell proliferation by gamma irradiation does not prevent the age-related increase of the number of dystrophin-positive fibers in soleus muscles of mdx female heterozygote mice. Am. J. Pathol. 138:1991;1497-1502.
26. Wirtz P., Loermans H., Rutten E. Effects of irradiation on regeneration in dystrophic mouse leg muscle. Br. J. Exp. Pathol. 63:1982;671-679.
27. Harris J. B., Johnson M. A., Karlsson E. Pathological responses of rat skeletal muscle to a single subcutaneous injection of a toxin from the venom of the Australian tiger snake, Notechis scutatus scutatus. Clin. Exp. Pharm. Physiol. 2:1975;383-404.
28. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold-Spring Harbor.
29. Sukenaga Y., Ishida K., Takeda T., Takagi K. cDNA sequence coding for human glutathione peroxidase. Nucleic Acids Res. 15:1987;7178.
30. Huard J., Acsadi G., Jani A., Massie B., Karpati G. Gene transfer into skeletal muscles by isogenic myoblasts. Hum. Gene Ther. 5:1994;949-958.
31. Beauchamp J. R., Morgan J. E., Pagel C. N., Partridge T. A. Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. J. Cell Biol. 144:1999;1113-1122.
32. Beauchamp J. R., Pagel C. N., Partridge T. A. A dual-marker system for quantitative studies of myoblast transplantation in the mouse. Transplantation. 63:1997;1794-1797.
33. Skuk D., Tremblay J. P. Complement deposition and cell death after myoblast transplantation. Cell Transplant. 7:1998;427-434.
34. Merly F., Huard C., Asselin I., Robbins P. D., Tremblay J. P. Anti-inflammatory effect of transforming growth factor-beta1 in myoblast transplantation. Transplantation. 65:1998;793-799.
35. Guerette B., Asselin I., Skuk D., Entman M., Tremblay J. P. Control of inflammatory damage by anti-LFA-1: Increase success of myoblast transplantation. Cell Transplant. 6:1997;101-107.
36. Guerette B., Skuk D., Celestin F., Huard C., Tardif F., Asselin I., Roy B., Goulet M., Roy R., Entman M., Tremblay J. P. Prevention by anti-LFA-1 of acute myoblast death following transplantation. J. Immunol. 159:1997;2522-2531.